{"id":"W3022362145","doi":"10.1007/s10067-020-05051-1","title":"Propensity score matching/reweighting analysis comparing intravenous golimumab to infliximab for ankylosing spondylitis using data from the GO-ALIVE and ASSERT trials","year":2020,"lang":"en","type":"article","venue":"Clinical Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"Janssen Scientific Affairs","keywords":"Golimumab; Medicine; Ankylosing spondylitis; Propensity score matching; Infliximab; BASFI; Internal medicine; BASDAI; Physical therapy; Rheumatoid arthritis; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03546223,0.0008753425,0.002678265,0.001160264,0.0004430237,0.0009989638,0.00119652,0.001049226,0.00406921],"category_scores_gemma":[0.05357265,0.0004228044,0.005886125,0.001580269,0.000554782,0.0007861074,0.0008885188,0.001242456,0.0003444889],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004917156,"about_ca_system_score_gemma":0.000798027,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001056564,"about_ca_topic_score_gemma":0.0006450929,"domain_scores_codex":[0.9631927,0.02839785,0.002569217,0.003011252,0.002285613,0.0005432805],"domain_scores_gemma":[0.977607,0.01136359,0.005752351,0.004120778,0.0008279152,0.0003283274],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2945578,0.001442717,0.4471567,0.002870284,0.1119108,0.0003997012,0.0002784548,0.02144362,0.002831384,0.003768582,0.008528969,0.104811],"study_design_scores_gemma":[0.09069318,0.0358245,0.5685099,0.0006682556,0.1122198,0.0008630172,0.0002687414,0.1586333,0.003690846,0.01390569,0.01448241,0.0002403979],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.948444,0.007388475,0.03252191,0.0007846071,0.0005580873,0.003715421,0.003929131,0.0001667475,0.00249157],"genre_scores_gemma":[0.990867,0.0004764259,0.004201618,0.0002411816,0.0001217273,0.00141522,0.002089194,0.00002341678,0.0005639681],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03546223,"threshold_uncertainty_score":0.1875445,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.451454809286212,"score_gpt":0.448748426629303,"score_spread":0.002706382656909034,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}